Issue link: http://osercommunicationsgroup.uberflip.com/i/709455
C h a i n D r u g s t o r e D a i l y M o n d a y, A u g u s t 8 , 2 0 1 6 1 2 DALE SMITH PRESENTED WITH NEXUS AWARD Dale Smith, Chief Executive Officer of H. D. Smith Holding Company, was recently honored by the HDA Research Foundation, Genentech Inc., a member of the Roche Group, and Mylan Inc., with the 2016 Nexus Award for Lifetime Achievement – the highest individual honor in the pharmaceutical distribution industry. Presented in June at the HDA 2016 Business and Leadership Conference, the Nexus Award recognizes exceptional character, professional accomplishments and leadership in HDA, the industry and community. "On the 60th anniversary of the Nexus Award, we are thrilled to celebrate Dale, whose vision has had an enormous impact on not only his company, but on HDA and the distribution industry as a whole," said John M. Gray, HDA President and Chief Executive Officer, and President, HDA Research Foundation. "The HDA Research Foundation is pleased to recognize him with the industry's most prestigious award." Smith follows in the footsteps of his father, Henry Dale Smith, Sr., and longtime H. D. Smith colleague Joseph Conda, Nexus Award honorees in 2003 and 1998, respectively. As the current Chairman and Chief Executive Officer of the parent company of H. D. Smith, Dale oversees all of H. D. Smith's business units, providing strate- gic direction and guidance alongside the company's board of directors. Under his leadership, the Springfield, Illinois-based H. D. Smith grew from a regional whole- saler to a national wholesaler – one of the largest independent wholesalers in the U.S. – with distribution centers spanning across the country. Further, Dale has led the com- pany to form greater partnerships with pharmaceutical manufacturers, and his guidance has allowed the company to provide a variety of services and solutions to help its cus- tomers, including retail and regional phar- macies, health systems and others, maxi- mize efficiencies when serving patients. He began his career at H. D. Smith in 1974, performing functions in nearly all of the company's departments. He also concurrently served as Vice Chairman and President of J M Smith Corporation in the 1990s, which was founded by his grandfather. Additionally, Dale is a Co-Founder of Wholesale Alliance, LLC, a coopera- tive with the mission of helping pharma- cies provide critical services. He chaired that organization from 1997 until 2005. Also in 2005, he was named the Illinois winner of the Entrepreneur of the Year Award in the Health Services/Life Sciences category. Recently, he spearheaded a joint venture between H. D. Smith and American Associated Pharmacies to form a new PSAO – Arete Pharmacy Network – and serves as Chairman of the Board. James Reilly, Vice President, Access & Channel Management, Genentech, Inc., and Vice Chairman, HDA Research Foundation, said, "Genentech is proud to support the 2016 Nexus Award, continu- ing the tradition of celebrating the indi- viduals who have shaped the future of the healthcare distribution industry. We con- gratulate Dale on this prestigious honor." "Dale is a shining example of the values this award embodies," said Robert Potter, Senior Vice President, North American National Accounts and Channel Development, Mylan Inc. For more information, visit booth #101. MALLINCKRODT EXPANDS SPECIALTY GENERICS CUSTOMER SERVICE Mallinckrodt Pharmaceuticals Specialty Generics business continues to focus on providing its customers greater connec- tivity and enhanced customer service to help them understand and benefit from broader value of the company's products, services and partnership. "Mallinckrodt brings decades of expertise to our Specialty Generics seg- ment and has a broad and diverse portfo- lio," says Roger Owen, Vice President, Business Operations of Multisource. "The company works to continually demonstrate its commitment to leader- ship through its ability to provide a reli- able source of supply, ensure quality and stay competitive in the marketplace. Mallinckrodt continually invests to main- tain the infrastructure, portfolio strength and breadth that allow it to respond effec- tively to market dynamics and customer needs." Earlier this year, the company pro- vided Specialty Generics customers with an expanded and enhanced customer service portal, building on its customized programs and collaborations that pro- vides transparent and timely information about product delivery and availability, as well as enable easy access to dedicat- ed customer service resources. Enhancements include: new dash- board capabilities that allow customers to quickly view orders, shipments, regis- tered users and open orders for last 90 days; customers can benefit from expanded chart and graphic reports that show rolling monthly order histories and service letters; expanded resources including HDMA forms, product labels and images, MSDS forms and media files – these provide customers information at their fingertips, and customers can bene- fit from updated search capabilities; around-the-clock access on both per- sonal computers and mobile and tablet devices, with updates provided in real-time and within a framework designed to work quickly and to be user- friendly; order tracking and exportable reporting capabilities, as well as email notifications. Feedback from customers has been extremely positive. Future enhancements are planned including invoicing, pricing, direct order entry, greater ability for cus- tomers to upload files and documents, contracting and trending burst reporting. Investments in technology are also met by improvements in operations. For Mallinckrodt, continuous improvement in people, infrastructure, technology and processes remain critical to producing quality products, delivered with integrity and through a commitment to customer service. For example, Mallinckrodt recently began construction of a new building that will improve Specialty Generics manufacturing at its St. Louis site. Completion of the more than $50 million project is expected in 2017 and will allow the company to modernize the manufactur- ing of key products. At Mallinckrodt's Hobart, New York plant, new packaging line equipment has helped improve equipment flexibility; the Hobart plant has also invested in the latest tablet press technology that helps make production more efficient. System upgrades were put in place at the company's plant in Raleigh, North Carolina. These investments represent how Mallinckrodt views its relationship with customers as a strategic partner – not just a supplier. "Mallinckrodt remains focused on staying customer-centric, demonstrating our commitment to our values and maintaining investments in our operations," Owen says. Visit Mallinckrodt Pharmaceuticals at booth #171. For more information, call 800.325.8888 or go to www .mallinckrodt.com. MOVING INTELLIGENCE, SERVICE OPTIONS INTO THE BACK OF YOUR PHARMACY By Jeff Pepperworth, President, Inmar Healthcare Network The operational environment for pharma- cies is ever-changing. Any one of the recent industry changes by itself comes with its own set of implications and chal- lenges: The Affordable Care Act and the move to value-based reimbursement; CMS' proposed rule; 340B Drug Program; DIR fees; industry consolida- tion; EPA Proposed Management Standards for Hazardous Waste Pharmaceuticals. The list goes on. Meeting the requirements of this shifting regulatory and competitive envi- ronment – all while trying to focus on spending more time on driving better out- comes to sustain profitability in the value based reimbursement model – requires the ability to adapt quickly, leveraging processes and tools that help maintain and improve operational efficiency. The pressure to innovate, integrate and imple- ment is intense. Pharmacies can't do all of this on their own and still have the time to spend on patient care; they need solutions that do more for them, and allow them to do that. These solutions need to leverage data, using it as a source of insights in a timely and centralized manner to drive operational efficiencies. Equally impor- tant is that the solutions align with the needs of store-level personnel and that they are easily implemented into current operations. Having inventory solutions in your pharmacy that can make all the decisions about hazardous waste is a great example. Hazardous-material man- agement is challenging. Among other things, it requires ongoing research and interpretation of regulations that are constantly changing, and significant personnel training and attention, demanding a time investment that likely comes at the expense of patient care and revenue and profit driving activities. In the proposed new rule, EPA shifts more hazardous waste responsibility to the store and exacerbates an existing quandary: a con- servative approach can lead to significant loss of product value recovery; converse- ly, a less stringent approach carries the risk of steep fines and tarnishing your reputation. Another example to consider is product returns. There are peaks and val- leys – staff turnover, seasonal fluctua- tions, vacation schedules and flu season - that impact a pharmacies' ability to man- age standard processes like returns, and might sometimes impact your ability to return product in a timely manner and the potential credit you are due. Additionally, some stores per- form really well in returns and others miss the mark, for a vari- ety of reasons you can't always control. There's more than opera- tional efficiency to be gained from hav- ing access to a hybrid reverse supply chain solution that combines automated, intuitive offsite service with an onsite service that can help you deal with peaks and valleys, or provide extra help to underperforming stores, and integrates hazardous disposition into the workflow at the back of your pharmacy. Our solu- tion allows your pharmacy to maximize value recovery, minimize risk and focus on what you need to: patient care. It doesn't stop there; we are commit- ted to continue investing in bringing intelligence and service options into the pharmacy. Visit Inmar at booth #1949. For more information, call 866.440.6917 or email solutions@inmar.com.